As Sussan Ley exits politics, her tenure as health minister is best remembered for driving some of the most structurally significant reforms to the Pharmaceutical Benefits Scheme in decades, reshaping pricing, governance, industry engagement, and patient access despite at times intense opposition. …
Sussan Ley's sometimes contentious but unquestionably consequential health legacy
February 15, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
Georgia Forrest
New Stories
-
Rare Cancers Australia sets sights on 2026 Kosi Challenge with renewed fundraising momentum
February 15, 2026 - - Latest News -
PBS spending is driven less by explicit fiscal choices and more by the flow of recommendations
February 15, 2026 - - Latest News -
Sussan Ley's sometimes contentious but unquestionably consequential health legacy
February 15, 2026 - - Latest News -
Australian medtech secures funds to advance real-time breast cancer surgery technology
February 13, 2026 - - Australian Biotech -
The Dispatched Podcast 'Week in Review' - 13 February
February 13, 2026 - - Podcast -
PBAC to reconsider broader vaccine funding after late addition to March agenda
February 13, 2026 - - Latest News -
Ten years of process 'improvements' is almost the point, says Anne Ruston
February 13, 2026 - - Latest News